Connor, Clark & Lunn Investment Management (CC&L)
HRMY icon

Connor, Clark & Lunn Investment Management (CC&L)’s Harmony Biosciences HRMY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$7.86M Buy
2025
Q1 		$3.79M Buy
2024
Q4 		– Sell
2024
Q3 		$359K Buy
2023
Q4 		– Sell
2023
Q3 		$286K Buy